Analyst Insights

Is CymaBay’s Seladelpar Back in the Saddle? 5-Star Analyst Weighs In

In the world of biotechs, all it takes is a single piece of good news to change the narrative. This has been exemplified …

Increased Focus on Health Will Benefit Herbalife, Says Analyst

COVID-19 has brought several trends to the fore. Online retail and grocery sales, cloud-based services for remote working, video conferencing apps – have …

3 Biotech Stocks Under $5 With Massive Upside Potential

Is it May 2020 or March 2009? As Wall Street observers traverse the confused economic environment, flashbacks of the Great Recession are coming …

MannKind (MNKD) Stock Could Nearly Double in the Next Year, Says Analyst

It has been a rough five years for investors of diabetes-focused biotech MannKind (MNKD). Over the period, shares of the company have declined …

3 Biotech Stocks Under $4 With at Least 50% Upside Potential

It has been almost three months since the coronavirus-driven volatility hit the global economy, and the market continues to rapidly move into both …

Under Armour Stock Could Stay Grounded… For Now

As COVID-19 has impacted even the most financially sturdy companies, the problems have been even more acute for those already in trouble before …

Despite Challenges, Plug Power Stock Is a Long-Term Winner

There are high hopes for the renewable energy sector, one on which Plug Power (PLUG) is attempting to leave its mark. Yet, the …

3 “Strong Buy” Penny Stocks with Massive Upside Ahead

Stocks are on the rise, but why? The glum results of earnings season have not caused another panic – rather, investors seem to be …

J.P. Morgan: 5G Ramp Provides Upside for These 2 Stocks

Which technology is set to take the world by storm? 5G, or fifth generation wireless.

RBC: 2 Strong Value Stocks to Buy Now

Which strategy is a favorite of billionaires like Warren Buffet and Benjamin Graham? Value investing.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts